NCT03570359View on ClinicalTrials.gov

A Study to Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza

PHASE2CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

January 29, 2018

Primary Completion Date

May 5, 2020

Study Completion Date

May 5, 2020

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Interferon Beta-1A

Interferon Beta-1A via inhalation

OTHER

Placebo

Placebo via inhalation

Trial Locations (16)

Unknown

Celerion, Belfast

Queen Elizabeth Hospital, Birmingham

Bradford Royal Infirmary, Bradford

Tower Family Health Care, Bury

Lakeside Healthcare, Corby

Gartnavel General Hospital, Glasgow

Hemel Hempstead Hospital, Hemel Hempstead

Hull Royal Infirmary, Hull

Liverpool Heart and Chest Hospital, Liverpool

Queen Anne Medical Centre, London

Royal Brompton, London

North Tyneside General Hospital, North Shields

The Adam Practice, Upton

M23 9QZ

Medicines Evaluation Unit, Manchester

NG7 2UH

Nottingham University Hospital NHS Trust, Nottingham

SO16 6YD

University Hospital Southampton NHS Foundation Trust, Southampton

All Listed Sponsors
lead

Synairgen Research Ltd.

INDUSTRY

NCT03570359 - A Study to Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza | Biotech Hunter | Biotech Hunter